The Independent Voice of
European Private Equity

Advanced Search

Ardian acquires majority stake in Neopharmed Gentili

Madeleine Farman 28 November 2018

Ardian has acquired a majority stake in therapeutic products business Neopharmed Gentili, a subsidiary of Italian pharmaceutical company Mediolanum Farmaceutici.

Ardian

Next article »

« Previous article

Related Articles

VC performance hits new high

23/07/19

Waterland-backed Median makes two deals

23/07/19

LBO France makes investment in Ecritel

23/07/19

Agilitas-backed Hydro makes second bolt-on

23/07/19

Innova Capital buys Optiplaza

23/07/19

Maven invests in computing company ebb3

23/07/19